Abstract:The currently available photosensitizers (PSs) for photodynamic therapy (PDT) can easily lead to undesirable normal cell death due to their intrinsic photo-toxicity and lack of selectivity for cancer cells. Activatable PSs with high therapeutic efficiency towards cancer cells but minimized side effects on normal cells are thus highly desirable. In this work, we developed a probe with dual-targeted activatable PSs that can recognize and ablate cancer cells with high selectivity. The probe is composed of a fluorophore with aggregation-induced emission (AIE) characteristics which can be used as an imaging agent as well as a PS, a quencher moiety that can be cleaved upon encountering biothiols, and a cyclic arginine-glycine-aspartic acid (cRGD) tripeptide for targeting cancer cells with overexpressed alpha(v)beta(3) integrin. The probe itself is non-fluorescent and its ability to generate reactive oxygen species (ROS) is prohibited. However, it could be selectively activated to offer specific fluorescence turn-on with efficient ROS generation in the aggregated state, which was used to ablate cancer cells overexpressing both alpha(v)beta(3) integrin receptors and glutathione. As compared to conventional activatable PSs which show quenched fluorescence and reduced ROS generation in the aggregated state, the dual-selection process with enhanced fluorescence and efficient ROS generation of the activated AIE probe in aggregated state offers a high signal-to-background ratio for MDA-MB-231 cancer cell imaging and ablation. This strategy thus opens up new opportunities for designing activatable PSs with high selectivity and low intrinsic photo-toxicity for photodynamic cancer cell ablation.

A Self-Reporting AIE Probe with a Built-in Singlet Oxygen Sensor for Targeted Photodynamic Ablation of Cancer Cells

Light‐Up Probe for Targeted and Activatable Photodynamic Therapy with Real‐Time In Situ Reporting of Sensitizer Activation and Therapeutic Responses

NIR-II Ratiometric Chemiluminescent/Fluorescent Reporters for Real-Time Monitoring and Evaluating Cancer Photodynamic Therapy Efficacy.

A De Novo Zwitterionic Strategy of Ultra-Stable Chemiluminescent Probes: Highly Selective Sensing of Singlet Oxygen in FDA-approved Phototherapy.

A unimolecular theranostic system with H2O2-specific response and AIE-activity for doxorubicin releasing and real-time tracking in living cells

A Fluorescent Nanoprobe for Real-Time Monitoring of Intracellular Singlet Oxygen During Photodynamic Therapy.

Ultra-high Signal-to-noise Ratio Near-Infrared Chemiluminescent Probe for in Vivo Sensing Singlet Oxygen

De Novo Zwitterionic Strategy of Ultra-stable Chemiluminescent Probes: Highly Selective Sensing Singlet Oxygen in FDA-approved Phototherapy

Specific Light-Up Bioprobe With Aggregation-Induced Emission And Activatable Photoactivity For The Targeted And Image-Guided Photodynamic Ablation Of Cancer Cells

A Novel Theranostic Nanoprobe for in Vivo Singlet Oxygen Detection and Real-Time Dose-Effect Relationship Monitoring in Photodynamic Therapy

Dual-targeted activatable photosensitizers with aggregation-induced emission (AIE) characteristics for image-guided photodynamic cancer cell ablation

An Aggregation-Induced Emission Photosensitizer with Efficient Singlet Oxygen Generation Capacity for Mitochondria Targeted Photodynamic Therapy

An Oxidation‐Enhanced Magnetic Resonance Imaging Probe for Visual and Specific Detection of Singlet Oxygen Generated in Photodynamic Cancer Therapy in Vivo

<i>In situ</i> construction of a self-assembled AIE probe for tumor hypoxia imaging

From Cell Membrane to Mitochondria: Time-dependent AIE Photosensitizer for Fluorescence Imaging and Photodynamic Anticancer Therapy

Aggregation-induced emission probes for cancer theranostics

Enzyme-Instructed Self-Assembly Leads To The Activation Of Optical Properties For Selective Fluorescence Detection And Photodynamic Ablation Of Cancer Cells

Molecular Engineering of Efficient Singlet Oxygen Generators with Near‐Infrared AIE Features for Mitochondrial Targeted Photodynamic Therapy

Bioorthogonal Turn-On Probe Based on Aggregation-Induced Emission Characteristics for Cancer Cell Imaging and Ablation.

A Singlet Oxygen Self-Reporting Photosensitizer for Cancer Phototherapy.

Photosensitizer-Singlet Oxygen Sensor Conjugated Silica Nanoparticles for Photodynamic Therapy and Bioimaging